Unknown

Dataset Information

0

Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer.

ABSTRACT:

SUBMITTER: Wall JA 

PROVIDER: S-EPMC7396249 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer.

Wall Jaclyn A JA   Arend Rebecca C RC  

Annals of translational medicine 20200701 13

Similar Datasets

Unknown Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
| S-EPMC4695147 | biostudies-literature
Unknown Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.
| S-EPMC7467966 | biostudies-literature
Unknown BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer.
| S-EPMC11320024 | biostudies-literature
Unknown Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway.
| S-EPMC5652704 | biostudies-literature
Unknown Antivascular therapy for epithelial ovarian cancer.
| S-EPMC2804796 | biostudies-literature
Unknown Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
| S-EPMC7537108 | biostudies-literature
Unknown USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway.
| S-EPMC10830728 | biostudies-literature
Unknown Visible light-activatable platinum(IV) prodrugs harnessing CD36 for ovarian cancer therapy.
| S-EPMC11298056 | biostudies-literature
Unknown Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging.
| S-EPMC4883985 | biostudies-literature
Unknown AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway.
| S-EPMC8580348 | biostudies-literature